Eloxx Pharmaceuticals Inc (ELOX)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$
Buy
$
$ (+%)
Prices updated at 14 Dec 2025, 17:40
| Prices minimum 15 mins delay
Prices in USD
Eloxx Pharmaceuticals Inc is a United States-based clinical-stage pharmaceutical company. It is focused on building and developing a portfolio of therapeutics for the treatment of cancer and immunological diseases.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
No data available
Valuation
No data available
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
| 2015 | - |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | 76.44 |
| 2015 | 56.59 |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2022 | -108.86 |
| 2021 | -186.35 |
| 2020 | -80.95 |
| 2019 | -92.78 |
| 2018 | -124.99 |
| 2017 | -154.41 |
| 2016 | -58.71 |
| 2015 | -71.49 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2022 | - |
| 2021 | 2.02 |
| 2020 | 2.59 |
| 2019 | 1.63 |
| 2018 | 1.18 |
| 2017 | 1.16 |
| 2016 | 2.02 |
| 2015 | 1.60 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
